Offerings (SEC Form D)
Each filing as reported by the issuer, newest first. Open a row for the full plain-English detail. D = original notice, D/A = amendment.
Offerings at a glance — 11 offerings, 14 filings (one row per SEC file number)
| File no. | Original Form D | Latest filing | Amendments | Offered (latest) | Sold (latest) | Industry (latest) |
|---|
| 021-340618 | May 29, 2019 EDGAR ↗ | May 29, 2019 D EDGAR ↗ | 0 | $36,266,376 | $26,266,376 | Other Health Care |
| 021-302831 | Jan 10, 2018 EDGAR ↗ | Feb 15, 2018 D/A EDGAR ↗ | 1 latest Feb 15, 2018 | $72,401,836 | $45,251,145 | Other Health Care |
| 021-274184 | Nov 10, 2016 EDGAR ↗ | Jan 9, 2017 D/A EDGAR ↗ | 1 latest Jan 9, 2017 | $55,000,004 | $55,000,004 | Other Health Care |
| 021-243408 | Jul 10, 2015 EDGAR ↗ | Jul 10, 2015 D EDGAR ↗ | 0 | $2,000,001 | $2,000,001 | Other Health Care |
| 021-217804 | May 22, 2014 EDGAR ↗ | May 22, 2014 D EDGAR ↗ | 0 | $4,500,001 | $4,500,001 | Other Health Care |
| 021-214761 | Apr 2, 2014 EDGAR ↗ | Apr 2, 2014 D EDGAR ↗ | 0 | $3,362,772 | $3,362,772 | Other Health Care |
| 021-213843 | Mar 18, 2014 EDGAR ↗ | Mar 18, 2014 D EDGAR ↗ | 0 | $500,000 | $500,000 | Other Health Care |
| 021-204035 | Oct 4, 2013 EDGAR ↗ | Jan 30, 2014 D/A EDGAR ↗ | 1 latest Jan 30, 2014 | $5,500,004 | $5,500,004 | Other Health Care |
| 021-187058 | Nov 15, 2012 EDGAR ↗ | Nov 15, 2012 D EDGAR ↗ | 0 | $1,138,994 | $539,999 | Other Health Care |
| 021-182423 | Aug 9, 2012 EDGAR ↗ | Aug 9, 2012 D EDGAR ↗ | 0 | $34,767,118 | $12,000,001 | Other Health Care |
| 021-138765 | Feb 17, 2010 EDGAR ↗ | Feb 17, 2010 D EDGAR ↗ | 0 | $64,220,317 | $40,683,990 | Pharmaceuticals |
Offerings are grouped by SEC file number; rows without a file number (not yet retrieved from EDGAR) are shown as their own offering until the link is fetched.
May 29, 2019 D Other Health Care — $26,266,376 sold of $36,266,376 · 15 investors EDGAR ↗
| Filing | Form D filed May 29, 2019SEC file no. 021-340618 · accession 0001484074-19-000001 |
|---|
| Raise progress | $26,266,376 sold of $36,266,376 offered (72%) · $10,000,000 remaining · first sale May 2, 2019 |
|---|
| Filing timing | Date of first sale: May 2, 2019 · Form D filed: May 29, 2019 (27 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
|---|
| Time since first sale | 2,732 days (7.5 years) |
|---|
| Annual amendments | Issuer reported the offering is not expected to last more than one year. No amendment for this offering in our index (filings 2008 → Oct 22, 2026; checked Oct 23, 2026, 5:45 PM ET). Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
|---|
| Investors | 15 total · issuer reported no non-accredited investors |
|---|
| Exemption claimed | Rule 506(b) — no general advertising; up to 35 non-accredited investors allowed |
|---|
| Minimum investment accepted | $0 as filed (no minimum reported) |
|---|
| Securities offered | Equity; Debt; Option, warrant or other right to acquire; Security to be acquired upon exercise |
|---|
| Entity details | Organized in DELAWARE · formed more than five years before filing · revenue range: Decline to Disclose (state and year as reported on the issuer's latest filing) As reported by the issuer on Form D (Items 1–2 and 5). |
|---|
| Industry | Other Health Care |
|---|
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
|---|
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 |
|---|
| Signed by | Tammy Cameron, Chief Financial Officer & Senior VP (May 28, 2019) |
|---|
| Market context | Minimum investment: $0 as filed (no minimum reported). Typical range for similar offerings: $10,000–$54,310.
Offering size: $36,266,376. Typical range: $829,831–$9,999,998.
Investors: 15. Typical range: 2–15."Similar" = Other Health Care, Rule 506(b). Based on 4,189 Form D filings 2021–2026 in the same industry and exemption (Other Health Care, Rule 506(b); original Form D notices, one per offering) (Form D data, SEC). Ranges are the middle half (25th–75th percentile) of the filings that reported each value: minimum investment 1,330, offering size 3,970, investors 3,669. Computed by PartnerFacts as of Oct 23, 2026, 5:45 PM ET. No ranking or score. Source: PartnerFacts data & coverage. |
|---|
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET |
|---|
Feb 15, 2018 D/A Other Health Care — $45,251,145 sold of $72,401,836 · 16 investors EDGAR ↗
| Filing | Form D/A (amendment) filed Feb 15, 2018 · amends 0001484074-18-000001 ↗SEC file no. 021-302831 · accession 0001484074-18-000003 · filing 2 of 2 in this offering |
|---|
| Raise progress | $45,251,145 sold of $72,401,836 offered (62%) · $27,150,691 remaining · first sale Dec 29, 2017 |
|---|
| Filing timing | Date of first sale: Dec 29, 2017 · Original Form D filed: Jan 10, 2018 (12 days after first sale) · This amendment (Form D/A) filed: Feb 15, 2018 This row is an amendment. Rule: the original Form D is generally due within 15 days after the first sale; the rule sets no deadline measured from an amendment. Dates shown as reported; no conclusion is drawn. |
|---|
| Time since first sale | 3,221 days (8.8 years) |
|---|
| Annual amendments | Issuer reported the offering is not expected to last more than one year. This filing is an amendment dated Feb 15, 2018. Most recent amendment for this offering in our index: this filing, Feb 15, 2018. Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
|---|
| Investors | 16 total · issuer reported no non-accredited investors |
|---|
| Exemption claimed | Rule 506(b) — no general advertising; up to 35 non-accredited investors allowed |
|---|
| Minimum investment accepted | $0 as filed (no minimum reported) |
|---|
| Securities offered | Equity |
|---|
| Entity details | Organized in DELAWARE · formed more than five years before filing · revenue range: Decline to Disclose (state and year as reported on the issuer's latest filing) As reported by the issuer on Form D (Items 1–2 and 5). |
|---|
| Industry | Other Health Care |
|---|
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
|---|
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 |
|---|
| Signed by | Robb Hesley, Senior VP Corporate Development & Finance (Feb 14, 2018) |
|---|
| Changes vs previous filing | - total sold: $43,943,213 (Jan 10, 2018) → $45,251,145 (Feb 15, 2018)
- total offering: $70,856,857 (Jan 10, 2018) → $72,401,836 (Feb 15, 2018)
- remaining: $26,913,644 (Jan 10, 2018) → $27,150,691 (Feb 15, 2018)
- investors: 11 (Jan 10, 2018) → 16 (Feb 15, 2018)
Compared with the D filed Jan 10, 2018 ( EDGAR ↗). Fields compared: total sold, total offering, remaining, investors, non-accredited investors (count), non-accredited investors reported, minimum investment, sales commissions, finder's fees, proceeds to insiders, date of first sale, industry, fund type, exemption, revenue range, net asset value range, securities offered, may last more than one year, related persons, sales-compensation recipients. Amendment history as filed; no conclusion is drawn. |
|---|
| Market context | Minimum investment: $0 as filed (no minimum reported). Typical range for similar offerings: $10,000–$54,310.
Offering size: $72,401,836. Typical range: $829,831–$9,999,998.
Investors: 16. Typical range: 2–15."Similar" = Other Health Care, Rule 506(b). Based on 4,189 Form D filings 2021–2026 in the same industry and exemption (Other Health Care, Rule 506(b); original Form D notices, one per offering) (Form D data, SEC). Ranges are the middle half (25th–75th percentile) of the filings that reported each value: minimum investment 1,330, offering size 3,970, investors 3,669. Computed by PartnerFacts as of Oct 23, 2026, 5:45 PM ET. No ranking or score. Source: PartnerFacts data & coverage. |
|---|
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET |
|---|
Jan 10, 2018 D Other Health Care — $43,943,213 sold of $70,856,857 · 11 investors EDGAR ↗
| Filing | Form D filed Jan 10, 2018SEC file no. 021-302831 · accession 0001484074-18-000001 · filing 1 of 2 in this offering |
|---|
| Raise progress | $43,943,213 sold of $70,856,857 offered (62%) · $26,913,644 remaining · first sale Dec 29, 2017 |
|---|
| Filing timing | Date of first sale: Dec 29, 2017 · Form D filed: Jan 10, 2018 (12 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
|---|
| Time since first sale | 3,221 days (8.8 years) |
|---|
| Annual amendments | Issuer reported the offering is not expected to last more than one year. Most recent amendment for this offering in our index: Feb 15, 2018 (EDGAR ↗). Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
|---|
| Investors | 11 total · issuer reported no non-accredited investors |
|---|
| Exemption claimed | Rule 506(b) — no general advertising; up to 35 non-accredited investors allowed |
|---|
| Minimum investment accepted | $0 as filed (no minimum reported) |
|---|
| Securities offered | Equity |
|---|
| Entity details | Organized in DELAWARE · formed more than five years before filing · revenue range: Decline to Disclose (state and year as reported on the issuer's latest filing) As reported by the issuer on Form D (Items 1–2 and 5). |
|---|
| Industry | Other Health Care |
|---|
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
|---|
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 |
|---|
| Signed by | Robb Hesley, Senior VP Corporate Development & Finance (Jan 9, 2018) |
|---|
| Market context | Minimum investment: $0 as filed (no minimum reported). Typical range for similar offerings: $10,000–$54,310.
Offering size: $70,856,857. Typical range: $829,831–$9,999,998.
Investors: 11. Typical range: 2–15."Similar" = Other Health Care, Rule 506(b). Based on 4,189 Form D filings 2021–2026 in the same industry and exemption (Other Health Care, Rule 506(b); original Form D notices, one per offering) (Form D data, SEC). Ranges are the middle half (25th–75th percentile) of the filings that reported each value: minimum investment 1,330, offering size 3,970, investors 3,669. Computed by PartnerFacts as of Oct 23, 2026, 5:45 PM ET. No ranking or score. Source: PartnerFacts data & coverage. |
|---|
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET |
|---|
Jan 9, 2017 D/A Other Health Care — $55,000,004 sold of $55,000,004 · 16 investors EDGAR ↗
| Filing | Form D/A (amendment) filed Jan 9, 2017 · amends 0001484074-16-000003 ↗SEC file no. 021-274184 · accession 0001484074-17-000001 · filing 2 of 2 in this offering |
|---|
| Raise progress | $55,000,004 sold of $55,000,004 offered (100%) · $0 remaining · first sale Oct 25, 2016 |
|---|
| Filing timing | Date of first sale: Oct 25, 2016 · Original Form D filed: Nov 10, 2016 (16 days after first sale) · This amendment (Form D/A) filed: Jan 9, 2017 This row is an amendment. Rule: the original Form D is generally due within 15 days after the first sale; the rule sets no deadline measured from an amendment. Dates shown as reported; no conclusion is drawn. |
|---|
| Time since first sale | 3,651 days (10.0 years) |
|---|
| Annual amendments | Issuer reported the offering is not expected to last more than one year. This filing is an amendment dated Jan 9, 2017. Most recent amendment for this offering in our index: this filing, Jan 9, 2017. Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
|---|
| Investors | 16 total · issuer reported no non-accredited investors |
|---|
| Exemption claimed | Rule 506(b) — no general advertising; up to 35 non-accredited investors allowed |
|---|
| Minimum investment accepted | $0 as filed (no minimum reported) |
|---|
| Securities offered | Equity |
|---|
| Entity details | Organized in DELAWARE · formed more than five years before filing · revenue range: Decline to Disclose (state and year as reported on the issuer's latest filing) As reported by the issuer on Form D (Items 1–2 and 5). |
|---|
| Industry | Other Health Care |
|---|
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
|---|
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 (est.) |
|---|
| Signed by | Emory V. Anderson, PRESIDENT AND CHIEF EXECUTIVE OFFICER (Dec 27, 2016) |
|---|
| Changes vs previous filing | - total sold: $40,000,003 (Nov 10, 2016) → $55,000,004 (Jan 9, 2017)
- total offering: $40,000,003 (Nov 10, 2016) → $55,000,004 (Jan 9, 2017)
- investors: 15 (Nov 10, 2016) → 16 (Jan 9, 2017)
- related persons added (Jan 9, 2017): Greg Garfield
Compared with the D filed Nov 10, 2016 ( EDGAR ↗). Fields compared: total sold, total offering, remaining, investors, non-accredited investors (count), non-accredited investors reported, minimum investment, sales commissions, finder's fees, proceeds to insiders, date of first sale, industry, fund type, exemption, revenue range, net asset value range, securities offered, may last more than one year, related persons, sales-compensation recipients. Amendment history as filed; no conclusion is drawn. |
|---|
| Market context | Minimum investment: $0 as filed (no minimum reported). Typical range for similar offerings: $10,000–$54,310.
Offering size: $55,000,004. Typical range: $829,831–$9,999,998.
Investors: 16. Typical range: 2–15."Similar" = Other Health Care, Rule 506(b). Based on 4,189 Form D filings 2021–2026 in the same industry and exemption (Other Health Care, Rule 506(b); original Form D notices, one per offering) (Form D data, SEC). Ranges are the middle half (25th–75th percentile) of the filings that reported each value: minimum investment 1,330, offering size 3,970, investors 3,669. Computed by PartnerFacts as of Oct 23, 2026, 5:45 PM ET. No ranking or score. Source: PartnerFacts data & coverage. |
|---|
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET |
|---|
Nov 10, 2016 D Other Health Care — $40,000,003 sold of $40,000,003 · 15 investors EDGAR ↗
| Filing | Form D filed Nov 10, 2016SEC file no. 021-274184 · accession 0001484074-16-000003 · filing 1 of 2 in this offering |
|---|
| Raise progress | $40,000,003 sold of $40,000,003 offered (100%) · $0 remaining · first sale Oct 25, 2016 |
|---|
| Filing timing | Date of first sale: Oct 25, 2016 · Form D filed: Nov 10, 2016 (16 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
|---|
| Time since first sale | 3,651 days (10.0 years) |
|---|
| Annual amendments | Issuer reported the offering is not expected to last more than one year. Most recent amendment for this offering in our index: Jan 9, 2017 (EDGAR ↗). Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
|---|
| Investors | 15 total · issuer reported no non-accredited investors |
|---|
| Exemption claimed | Rule 506(b) — no general advertising; up to 35 non-accredited investors allowed |
|---|
| Minimum investment accepted | $0 as filed (no minimum reported) |
|---|
| Securities offered | Equity |
|---|
| Entity details | Organized in DELAWARE · formed more than five years before filing · revenue range: Decline to Disclose (state and year as reported on the issuer's latest filing) As reported by the issuer on Form D (Items 1–2 and 5). |
|---|
| Industry | Other Health Care |
|---|
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
|---|
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 (est.) |
|---|
| Signed by | Emory V. Anderson, PRESIDENT AND CHIEF EXECUTIVE OFFICER (Nov 1, 2016) |
|---|
| Market context | Minimum investment: $0 as filed (no minimum reported). Typical range for similar offerings: $10,000–$54,310.
Offering size: $40,000,003. Typical range: $829,831–$9,999,998.
Investors: 15. Typical range: 2–15."Similar" = Other Health Care, Rule 506(b). Based on 4,189 Form D filings 2021–2026 in the same industry and exemption (Other Health Care, Rule 506(b); original Form D notices, one per offering) (Form D data, SEC). Ranges are the middle half (25th–75th percentile) of the filings that reported each value: minimum investment 1,330, offering size 3,970, investors 3,669. Computed by PartnerFacts as of Oct 23, 2026, 5:45 PM ET. No ranking or score. Source: PartnerFacts data & coverage. |
|---|
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET |
|---|
Jul 10, 2015 D Other Health Care — $2,000,001 sold of $2,000,001 · 11 investors EDGAR ↗
| Filing | Form D filed Jul 10, 2015SEC file no. 021-243408 · accession 0001484074-15-000002 |
|---|
| Raise progress | $2,000,001 sold of $2,000,001 offered (100%) · $0 remaining · first sale Jul 8, 2015 |
|---|
| Filing timing | Date of first sale: Jul 8, 2015 · Form D filed: Jul 10, 2015 (2 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
|---|
| Time since first sale | 4,126 days (11.3 years) |
|---|
| Annual amendments | Issuer reported the offering is not expected to last more than one year. No amendment for this offering in our index (filings 2008 → Oct 22, 2026; checked Oct 23, 2026, 5:45 PM ET). Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
|---|
| Investors | 11 total · issuer reported no non-accredited investors |
|---|
| Exemption claimed | Rule 506(b) — no general advertising; up to 35 non-accredited investors allowed |
|---|
| Minimum investment accepted | $0 as filed (no minimum reported) |
|---|
| Securities offered | Equity; Debt |
|---|
| Entity details | Organized in DELAWARE · formed more than five years before filing · revenue range: Decline to Disclose (state and year as reported on the issuer's latest filing) As reported by the issuer on Form D (Items 1–2 and 5). |
|---|
| Industry | Other Health Care |
|---|
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
|---|
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 |
|---|
| Signed by | Emory V. Anderson, PRESIDENT AND CHIEF EXECUTIVE OFFICER (Jul 9, 2015) |
|---|
| Market context | Minimum investment: $0 as filed (no minimum reported). Typical range for similar offerings: $10,000–$54,310.
Offering size: $2,000,001. Typical range: $829,831–$9,999,998.
Investors: 11. Typical range: 2–15."Similar" = Other Health Care, Rule 506(b). Based on 4,189 Form D filings 2021–2026 in the same industry and exemption (Other Health Care, Rule 506(b); original Form D notices, one per offering) (Form D data, SEC). Ranges are the middle half (25th–75th percentile) of the filings that reported each value: minimum investment 1,330, offering size 3,970, investors 3,669. Computed by PartnerFacts as of Oct 23, 2026, 5:45 PM ET. No ranking or score. Source: PartnerFacts data & coverage. |
|---|
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET |
|---|
May 22, 2014 D Other Health Care — $4,500,001 sold of $4,500,001 · 11 investors EDGAR ↗
| Filing | Form D filed May 22, 2014SEC file no. 021-217804 · accession 0001484074-14-000004 |
|---|
| Raise progress | $4,500,001 sold of $4,500,001 offered (100%) · $0 remaining · first sale May 15, 2014 |
|---|
| Filing timing | Date of first sale: May 15, 2014 · Form D filed: May 22, 2014 (7 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
|---|
| Time since first sale | 4,545 days (12.5 years) |
|---|
| Annual amendments | Issuer reported the offering is not expected to last more than one year. No amendment for this offering in our index (filings 2008 → Oct 22, 2026; checked Oct 23, 2026, 5:45 PM ET). Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
|---|
| Investors | 11 total · issuer reported no non-accredited investors |
|---|
| Exemption claimed | Rule 506(b) — no general advertising; up to 35 non-accredited investors allowed |
|---|
| Minimum investment accepted | $0 as filed (no minimum reported) |
|---|
| Securities offered | Equity; Debt |
|---|
| Entity details | Organized in DELAWARE · formed more than five years before filing · revenue range: Decline to Disclose (state and year as reported on the issuer's latest filing) As reported by the issuer on Form D (Items 1–2 and 5). |
|---|
| Industry | Other Health Care |
|---|
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
|---|
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 |
|---|
| Signed by | Michael W. Hall, Secretary (May 19, 2014) |
|---|
| Market context | Minimum investment: $0 as filed (no minimum reported). Typical range for similar offerings: $10,000–$54,310.
Offering size: $4,500,001. Typical range: $829,831–$9,999,998.
Investors: 11. Typical range: 2–15."Similar" = Other Health Care, Rule 506(b). Based on 4,189 Form D filings 2021–2026 in the same industry and exemption (Other Health Care, Rule 506(b); original Form D notices, one per offering) (Form D data, SEC). Ranges are the middle half (25th–75th percentile) of the filings that reported each value: minimum investment 1,330, offering size 3,970, investors 3,669. Computed by PartnerFacts as of Oct 23, 2026, 5:45 PM ET. No ranking or score. Source: PartnerFacts data & coverage. |
|---|
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET |
|---|
Apr 2, 2014 D Other Health Care — $3,362,772 sold of $3,362,772 · 17 investors EDGAR ↗
| Filing | Form D filed Apr 2, 2014SEC file no. 021-214761 · accession 0001484074-14-000003 |
|---|
| Raise progress | $3,362,772 sold of $3,362,772 offered (100%) · $0 remaining · first sale Mar 24, 2014 |
|---|
| Filing timing | Date of first sale: Mar 24, 2014 · Form D filed: Apr 2, 2014 (9 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
|---|
| Time since first sale | 4,597 days (12.6 years) |
|---|
| Annual amendments | Issuer reported the offering is not expected to last more than one year. No amendment for this offering in our index (filings 2008 → Oct 22, 2026; checked Oct 23, 2026, 5:45 PM ET). Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
|---|
| Investors | 17 total · issuer reported no non-accredited investors |
|---|
| Exemption claimed | Rule 506(b) — no general advertising; up to 35 non-accredited investors allowed |
|---|
| Minimum investment accepted | $0 as filed (no minimum reported) |
|---|
| Securities offered | Equity; Debt; Option, warrant or other right to acquire; Security to be acquired upon exercise |
|---|
| Entity details | Organized in DELAWARE · formed more than five years before filing · revenue range: Decline to Disclose (state and year as reported on the issuer's latest filing) As reported by the issuer on Form D (Items 1–2 and 5). |
|---|
| Industry | Other Health Care |
|---|
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
|---|
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 |
|---|
| Signed by | Michael W. Hall, Secretary (Apr 2, 2014) |
|---|
| Market context | Minimum investment: $0 as filed (no minimum reported). Typical range for similar offerings: $10,000–$54,310.
Offering size: $3,362,772. Typical range: $829,831–$9,999,998.
Investors: 17. Typical range: 2–15."Similar" = Other Health Care, Rule 506(b). Based on 4,189 Form D filings 2021–2026 in the same industry and exemption (Other Health Care, Rule 506(b); original Form D notices, one per offering) (Form D data, SEC). Ranges are the middle half (25th–75th percentile) of the filings that reported each value: minimum investment 1,330, offering size 3,970, investors 3,669. Computed by PartnerFacts as of Oct 23, 2026, 5:45 PM ET. No ranking or score. Source: PartnerFacts data & coverage. |
|---|
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET |
|---|
Mar 18, 2014 D Other Health Care — $500,000 sold of $500,000 · 11 investors EDGAR ↗
| Filing | Form D filed Mar 18, 2014SEC file no. 021-213843 · accession 0001484074-14-000002 |
|---|
| Raise progress | $500,000 sold of $500,000 offered (100%) · $0 remaining · first sale Mar 10, 2014 |
|---|
| Filing timing | Date of first sale: Mar 10, 2014 · Form D filed: Mar 18, 2014 (8 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
|---|
| Time since first sale | 4,611 days (12.6 years) |
|---|
| Annual amendments | Issuer reported the offering is not expected to last more than one year. No amendment for this offering in our index (filings 2008 → Oct 22, 2026; checked Oct 23, 2026, 5:45 PM ET). Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
|---|
| Investors | 11 total · issuer reported no non-accredited investors |
|---|
| Exemption claimed | Rule 506(b) — no general advertising; up to 35 non-accredited investors allowed |
|---|
| Minimum investment accepted | $0 as filed (no minimum reported) |
|---|
| Securities offered | Debt |
|---|
| Entity details | Organized in DELAWARE · formed more than five years before filing · revenue range: Decline to Disclose (state and year as reported on the issuer's latest filing) As reported by the issuer on Form D (Items 1–2 and 5). |
|---|
| Industry | Other Health Care |
|---|
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
|---|
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 |
|---|
| Signed by | Michael W. Hall, Secretary (Mar 14, 2014) |
|---|
| Market context | Minimum investment: $0 as filed (no minimum reported). Typical range for similar offerings: $10,000–$54,310.
Offering size: $500,000. Typical range: $829,831–$9,999,998.
Investors: 11. Typical range: 2–15."Similar" = Other Health Care, Rule 506(b). Based on 4,189 Form D filings 2021–2026 in the same industry and exemption (Other Health Care, Rule 506(b); original Form D notices, one per offering) (Form D data, SEC). Ranges are the middle half (25th–75th percentile) of the filings that reported each value: minimum investment 1,330, offering size 3,970, investors 3,669. Computed by PartnerFacts as of Oct 23, 2026, 5:45 PM ET. No ranking or score. Source: PartnerFacts data & coverage. |
|---|
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET |
|---|
Jan 30, 2014 D/A Other Health Care — $5,500,004 sold of $5,500,004 · 17 investors EDGAR ↗
| Filing | Form D/A (amendment) filed Jan 30, 2014 · amends 0001484074-13-000001 ↗SEC file no. 021-204035 · accession 0001484074-14-000001 · filing 2 of 2 in this offering |
|---|
| Raise progress | $5,500,004 sold of $5,500,004 offered (100%) · $0 remaining · first sale Sep 25, 2013 |
|---|
| Filing timing | Date of first sale: Sep 25, 2013 · Original Form D filed: Oct 4, 2013 (9 days after first sale) · This amendment (Form D/A) filed: Jan 30, 2014 This row is an amendment. Rule: the original Form D is generally due within 15 days after the first sale; the rule sets no deadline measured from an amendment. Dates shown as reported; no conclusion is drawn. |
|---|
| Time since first sale | 4,777 days (13.1 years) |
|---|
| Annual amendments | Issuer reported the offering is not expected to last more than one year. This filing is an amendment dated Jan 30, 2014. Most recent amendment for this offering in our index: this filing, Jan 30, 2014. Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
|---|
| Investors | 17 total · issuer reported no non-accredited investors |
|---|
| Exemption claimed | Rule 506(b) — no general advertising; up to 35 non-accredited investors allowed |
|---|
| Minimum investment accepted | $0 as filed (no minimum reported) |
|---|
| Securities offered | Equity; Debt |
|---|
| Entity details | Organized in DELAWARE · formed more than five years before filing · revenue range: Decline to Disclose (state and year as reported on the issuer's latest filing) As reported by the issuer on Form D (Items 1–2 and 5). |
|---|
| Industry | Other Health Care |
|---|
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
|---|
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 |
|---|
| Signed by | Michael W. Hall, Secretary (Jan 30, 2014) |
|---|
| Changes vs previous filing | - total sold: $4,000,003 (Oct 4, 2013) → $5,500,004 (Jan 30, 2014)
- total offering: $4,000,003 (Oct 4, 2013) → $5,500,004 (Jan 30, 2014)
- related persons added (Jan 30, 2014): Charles Larsen
- related persons no longer listed (Jan 30, 2014): Gerard van Hamel Platerink
Compared with the D filed Oct 4, 2013 ( EDGAR ↗). Fields compared: total sold, total offering, remaining, investors, non-accredited investors (count), non-accredited investors reported, minimum investment, sales commissions, finder's fees, proceeds to insiders, date of first sale, industry, fund type, exemption, revenue range, net asset value range, securities offered, may last more than one year, related persons, sales-compensation recipients. Amendment history as filed; no conclusion is drawn. |
|---|
| Market context | Minimum investment: $0 as filed (no minimum reported). Typical range for similar offerings: $10,000–$54,310.
Offering size: $5,500,004. Typical range: $829,831–$9,999,998.
Investors: 17. Typical range: 2–15."Similar" = Other Health Care, Rule 506(b). Based on 4,189 Form D filings 2021–2026 in the same industry and exemption (Other Health Care, Rule 506(b); original Form D notices, one per offering) (Form D data, SEC). Ranges are the middle half (25th–75th percentile) of the filings that reported each value: minimum investment 1,330, offering size 3,970, investors 3,669. Computed by PartnerFacts as of Oct 23, 2026, 5:45 PM ET. No ranking or score. Source: PartnerFacts data & coverage. |
|---|
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET |
|---|
Oct 4, 2013 D Other Health Care — $4,000,003 sold of $4,000,003 · 17 investors EDGAR ↗
| Filing | Form D filed Oct 4, 2013SEC file no. 021-204035 · accession 0001484074-13-000001 · filing 1 of 2 in this offering |
|---|
| Raise progress | $4,000,003 sold of $4,000,003 offered (100%) · $0 remaining · first sale Sep 25, 2013 |
|---|
| Filing timing | Date of first sale: Sep 25, 2013 · Form D filed: Oct 4, 2013 (9 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
|---|
| Time since first sale | 4,777 days (13.1 years) |
|---|
| Annual amendments | Issuer reported the offering is not expected to last more than one year. Most recent amendment for this offering in our index: Jan 30, 2014 (EDGAR ↗). Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
|---|
| Investors | 17 total · issuer reported no non-accredited investors |
|---|
| Exemption claimed | Rule 506(b) — no general advertising; up to 35 non-accredited investors allowed |
|---|
| Minimum investment accepted | $0 as filed (no minimum reported) |
|---|
| Securities offered | Equity; Debt |
|---|
| Entity details | Organized in DELAWARE · formed more than five years before filing · revenue range: Decline to Disclose (state and year as reported on the issuer's latest filing) As reported by the issuer on Form D (Items 1–2 and 5). |
|---|
| Industry | Other Health Care |
|---|
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
|---|
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 |
|---|
| Signed by | Michael W. Hall, Secretary (Oct 4, 2013) |
|---|
| Market context | Minimum investment: $0 as filed (no minimum reported). Typical range for similar offerings: $10,000–$54,310.
Offering size: $4,000,003. Typical range: $829,831–$9,999,998.
Investors: 17. Typical range: 2–15."Similar" = Other Health Care, Rule 506(b). Based on 4,189 Form D filings 2021–2026 in the same industry and exemption (Other Health Care, Rule 506(b); original Form D notices, one per offering) (Form D data, SEC). Ranges are the middle half (25th–75th percentile) of the filings that reported each value: minimum investment 1,330, offering size 3,970, investors 3,669. Computed by PartnerFacts as of Oct 23, 2026, 5:45 PM ET. No ranking or score. Source: PartnerFacts data & coverage. |
|---|
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET |
|---|
Nov 15, 2012 D Other Health Care — $539,999 sold of $1,138,994 · 2 investors EDGAR ↗
| Filing | Form D filed Nov 15, 2012SEC file no. 021-187058 · accession 0001484074-12-000002 |
|---|
| Raise progress | $539,999 sold of $1,138,994 offered (47%) · $598,995 remaining · first sale Oct 29, 2012 |
|---|
| Filing timing | Date of first sale: Oct 29, 2012 · Form D filed: Nov 15, 2012 (17 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
|---|
| Time since first sale | 5,108 days (14.0 years) |
|---|
| Annual amendments | Issuer reported the offering is not expected to last more than one year. No amendment for this offering in our index (filings 2008 → Oct 22, 2026; checked Oct 23, 2026, 5:45 PM ET). Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
|---|
| Investors | 2 total · issuer reported no non-accredited investors |
|---|
| Exemption claimed | Rule 506 (filed before Sept 2013, when 506 was split into 506(b) and 506(c)) |
|---|
| Minimum investment accepted | $0 as filed (no minimum reported) |
|---|
| Securities offered | Option, warrant or other right to acquire; Security to be acquired upon exercise |
|---|
| Entity details | Organized in DELAWARE · formed more than five years before filing · revenue range: Decline to Disclose (state and year as reported on the issuer's latest filing) As reported by the issuer on Form D (Items 1–2 and 5). |
|---|
| Industry | Other Health Care |
|---|
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
|---|
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 |
|---|
| Signed by | Michael W. Hall, Secretary (Nov 15, 2012) |
|---|
| Market context | Not computed — the exemption as filed is Rule 506 before the Sept 2013 split into 506(b) and 506(c) (see Exemption claimed); ranges are computed only for offerings claiming Rule 506(b) or 506(c), compared with the last 5 years of filings. |
|---|
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET |
|---|
Aug 9, 2012 D Other Health Care — $12,000,001 sold of $34,767,118 · 17 investors EDGAR ↗
| Filing | Form D filed Aug 9, 2012SEC file no. 021-182423 · accession 0001484074-12-000001 |
|---|
| Raise progress | $12,000,001 sold of $34,767,118 offered (35%) · $22,767,117 remaining · first sale Aug 3, 2012 |
|---|
| Filing timing | Date of first sale: Aug 3, 2012 · Form D filed: Aug 9, 2012 (6 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
|---|
| Time since first sale | 5,195 days (14.2 years) |
|---|
| Annual amendments | Issuer reported the offering may last more than one year. No amendment for this offering in our index (filings 2008 → Oct 22, 2026; checked Oct 23, 2026, 5:45 PM ET). Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
|---|
| Investors | 17 total · issuer reported no non-accredited investors |
|---|
| Exemption claimed | Rule 506 (filed before Sept 2013, when 506 was split into 506(b) and 506(c)) |
|---|
| Minimum investment accepted | $0 as filed (no minimum reported) |
|---|
| Securities offered | Equity; Option, warrant or other right to acquire; Security to be acquired upon exercise |
|---|
| Entity details | Organized in DELAWARE · formed more than five years before filing · revenue range: Decline to Disclose (state and year as reported on the issuer's latest filing) As reported by the issuer on Form D (Items 1–2 and 5). |
|---|
| Industry | Other Health Care |
|---|
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
|---|
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 |
|---|
| Signed by | Michael W. Hall, Secretary (Aug 8, 2012) |
|---|
| Market context | Not computed — the exemption as filed is Rule 506 before the Sept 2013 split into 506(b) and 506(c) (see Exemption claimed); ranges are computed only for offerings claiming Rule 506(b) or 506(c), compared with the last 5 years of filings. |
|---|
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET |
|---|
Feb 17, 2010 D Pharmaceuticals — $40,683,990 sold of $64,220,317 · 19 investors EDGAR ↗
| Filing | Form D filed Feb 17, 2010SEC file no. 021-138765 · accession 0001484074-10-000001 |
|---|
| Raise progress | $40,683,990 sold of $64,220,317 offered (63%) · $23,536,327 remaining · first sale Dec 22, 2009 |
|---|
| Filing timing | Date of first sale: Dec 22, 2009 · Form D filed: Feb 17, 2010 (57 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
|---|
| Time since first sale | 6,150 days (16.8 years) |
|---|
| Annual amendments | Issuer reported the offering is not expected to last more than one year. No amendment for this offering in our index (filings 2008 → Oct 22, 2026; checked Oct 23, 2026, 5:45 PM ET). Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
|---|
| Investors | 19 total · issuer reported no non-accredited investors |
|---|
| Exemption claimed | Rule 506 (filed before Sept 2013, when 506 was split into 506(b) and 506(c)) |
|---|
| Minimum investment accepted | $0 as filed (no minimum reported) |
|---|
| Securities offered | Equity |
|---|
| Entity details | Organized in DELAWARE · formed more than five years before filing · revenue range: Decline to Disclose (state and year as reported on the issuer's latest filing) As reported by the issuer on Form D (Items 1–2 and 5). |
|---|
| Industry | Pharmaceuticals |
|---|
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
|---|
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 |
|---|
| Signed by | Michael W. Hall, Secretary (Feb 16, 2010) |
|---|
| Market context | Not computed — the exemption as filed is Rule 506 before the Sept 2013 split into 506(b) and 506(c) (see Exemption claimed); ranges are computed only for offerings claiming Rule 506(b) or 506(c), compared with the last 5 years of filings. |
|---|
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET |
|---|
Amendment history — 3 amendments on this page, each compared with the filing before it in the same offering
| Amendment filed | File no. | Compared with | What changed (both values as filed) |
|---|
| Feb 15, 2018 EDGAR ↗ | 021-302831 | Jan 10, 2018 D | total sold: $43,943,213 (Jan 10, 2018) → $45,251,145 (Feb 15, 2018) · total offering: $70,856,857 (Jan 10, 2018) → $72,401,836 (Feb 15, 2018) · remaining: $26,913,644 (Jan 10, 2018) → $27,150,691 (Feb 15, 2018) · and 1 more (open the filing above) |
| Jan 9, 2017 EDGAR ↗ | 021-274184 | Nov 10, 2016 D | total sold: $40,000,003 (Nov 10, 2016) → $55,000,004 (Jan 9, 2017) · total offering: $40,000,003 (Nov 10, 2016) → $55,000,004 (Jan 9, 2017) · investors: 15 (Nov 10, 2016) → 16 (Jan 9, 2017) · and 1 more (open the filing above) |
| Jan 30, 2014 EDGAR ↗ | 021-204035 | Oct 4, 2013 D | total sold: $4,000,003 (Oct 4, 2013) → $5,500,004 (Jan 30, 2014) · total offering: $4,000,003 (Oct 4, 2013) → $5,500,004 (Jan 30, 2014) · related persons added (Jan 30, 2014): Charles Larsen · and 1 more (open the filing above) |
Fields compared: total sold, total offering, remaining, investors, non-accredited investors (count), non-accredited investors reported, minimum investment, sales commissions, finder's fees, proceeds to insiders, date of first sale, industry, fund type, exemption, revenue range, net asset value range, securities offered, may last more than one year, related persons, sales-compensation recipients. Values as filed; no conclusion is drawn.
All Form D filings for this CIK on SEC EDGAR ↗. History: 0 new offerings in the last 12 months (new offering = a Form D that is not an amendment) · most recent filing May 29, 2019. Industry as reported, by offering: Previous offerings: Pharmaceuticals (2010). Latest offering: Other Health Care (2012–2019; most recent May 29, 2019).
Key people 20
Officers, directors and promoters the issuer itself named on its Form D. Tap a name for every other deal they are on.
| Name | Relationship | Address state | On filings (first → last) | Also listed on |
|---|
| CT Casey Tansey | Director | CA | Feb 17, 2010 → May 29, 2019 on 14 of 14 filings listed on the latest filing | 25 other issuers |
| CL Charles Larsen | Director | CA | Jan 30, 2014 → May 29, 2019 on 8 of 14 filings listed on the latest filing | 7 other issuers |
| EA Emory V. Anderson also filed as Emory Anderson, III | Executive Officer, Director | CA | Feb 17, 2010 → May 29, 2019 on 14 of 14 filings listed on the latest filing | 1 other issuer |
| MC Matthew Crawford | Director | CA | Nov 10, 2016 → May 29, 2019 on 5 of 14 filings listed on the latest filing | 8 other issuers |
| MB Michael Bornitz | Director | CA | Jan 10, 2018 → May 29, 2019 on 3 of 14 filings listed on the latest filing | 1 other issuer |
| RR Rebecca Robertson | Director | CA | Feb 17, 2010 → May 29, 2019 on 14 of 14 filings listed on the latest filing | 8 other issuers |
| RH Robb Hesley | Executive Officer | CA | Aug 9, 2012 → May 29, 2019 on 13 of 14 filings listed on the latest filing | — |
| VS Valeska Schroeder | Director | CA | May 29, 2019 on 1 of 14 filings listed on the latest filing | 2 other issuers |
| GG Gregory Garfield | Director | CA | Jan 10, 2018 → Feb 15, 2018 on 2 of 14 filings not listed on the latest filing (May 29, 2019) | 1 other issuer |
| SC Stephen Campe | Director | United Kingdom (as filed: X0) | Feb 17, 2010 → Feb 15, 2018 on 13 of 14 filings not listed on the latest filing (May 29, 2019) | — |
| AD Anders Hove, M.D. | Director | CA | Aug 9, 2012 → Jan 9, 2017 on 10 of 14 filings not listed on the latest filing (May 29, 2019) | — |
| GB Glen Bradley | Director | CA | Feb 17, 2010 → Jan 9, 2017 on 11 of 14 filings not listed on the latest filing (May 29, 2019) | — |
| GG Greg Garfield | Director | CA | Jan 9, 2017 on 1 of 14 filings not listed on the latest filing (May 29, 2019) | 10 other issuers |
| RT Richard Thompson | Director | CA | Feb 17, 2010 → Jan 9, 2017 on 11 of 14 filings not listed on the latest filing (May 29, 2019) | 9 other issuers |
| KL Kelley Lipman | Executive Officer | CA | Feb 17, 2010 → May 22, 2014 on 8 of 14 filings not listed on the latest filing (May 29, 2019) | — |
| ED Eric Aguiar, M.D. | Director | CA | Oct 4, 2013 → Apr 2, 2014 on 4 of 14 filings not listed on the latest filing (May 29, 2019) | — |
| GP Gerard van Hamel Platerink | Director | CA | Aug 9, 2012 → Oct 4, 2013 on 3 of 14 filings not listed on the latest filing (May 29, 2019) | 8 other issuers |
| PM Peter McNerney | Director | MN | Feb 17, 2010 → Nov 15, 2012 on 3 of 14 filings not listed on the latest filing (May 29, 2019) | 6 other issuers |
| NL Nelson Lam | Executive Officer | CA | Feb 17, 2010 → Aug 9, 2012 on 2 of 14 filings not listed on the latest filing (May 29, 2019) | — |
| JH John Howard | Executive Officer | CA | Feb 17, 2010 on 1 of 14 filings not listed on the latest filing (May 29, 2019) | 10 other issuers |
Executive officers, directors and promoters as self-reported by the issuer, one row per person. Spellings of the same name (same first and last name, or the same full name that EDGAR split differently into middle and last name) with no conflicting middle initial are shown on one row (none on this issuer); dates and counts come from the filings that list each name. Licensed persons: FINRA BrokerCheck ↗ · SEC IAPD ↗. Middle names: the SEC Form D data set (RELATEDPERSONS.tsv) repeats the previous person's middle name into later rows of the same filing; where that happened PartnerFacts shows the name without the repeated middle name and keeps the data-set spelling on record (Casey V. Tansey; Charles V. Larsen; Matthew V. Crawford; Michael V. Bornitz; Rebecca V. Robertson; Robb V. Hesley; Valeska V. Schroeder; Gregory V. Garfield; Stephen V. Campe; Anders V. Hove, M.D.; Glen V. Bradley; Greg V. Garfield; Richard V. Thompson; Kelley V. Lipman; Eric V. Aguiar, M.D.; Gerard V. van Hamel Platerink; Peter V. McNerney; Nelson V. Lam) — the filing on EDGAR is the source.
Connections
Other issuers listing the same people (showing 40 of 96):
- FEMASYS INC — Charles Larsen · latest filing Aug 20, 2026
- U.S. Venture Partners XIV, L.P. — Casey Tansey · latest filing Jul 31, 2026
- Cagent Vascular, Inc. — Casey Tansey · latest filing Jun 5, 2026
- Skims Body, Inc. — John Howard · latest filing Dec 19, 2025
- Iantrek, Inc. — Casey Tansey · latest filing Aug 21, 2025
- Neuros Medical, Inc. — Casey Tansey · latest filing Aug 6, 2025
- HeartFlow Holding, Inc. — Casey Tansey · latest filing Apr 11, 2025
- SHOULDER INNOVATIONS, INC. — Casey Tansey · latest filing Mar 18, 2025
- MicroTransponder, Inc. — Casey Tansey · latest filing Mar 14, 2025
- NEOCHORD INC — Casey Tansey · latest filing Mar 13, 2025
- Earlens Corp — Greg Garfield · latest filing Mar 3, 2025
- U.S. Venture Partners Select Fund I-A, L.P. — Casey Tansey · latest filing Feb 25, 2025
- Aerin Medical Inc. — Gregory Garfield · latest filing Dec 30, 2024
- Aerin Medical Inc. — Greg Garfield · latest filing Dec 30, 2024
- Aerin Medical Inc. — Valeska Schroeder · latest filing Dec 30, 2024
- U.S. Venture Partners Select Fund I, L.P. — Casey Tansey · latest filing Oct 17, 2024
- ShiraTronics, Inc — Casey Tansey · latest filing Sep 30, 2024
- CLEANBOSS, INC. — John Howard · latest filing Jul 9, 2024
- Cannabist Co Holdings Inc. — John Howard · latest filing Apr 3, 2024
- RefleXion Medical, Inc. — Greg Garfield · latest filing Nov 22, 2023
- Augmedix, Inc. — Gerard van Hamel Platerink · latest filing May 3, 2023
- Wolf & Shepherd, Inc. — John Howard · latest filing Mar 31, 2023
- CardioFocus, Inc. — Charles Larsen · latest filing Feb 24, 2023
- U.S. Venture Partners XIII, L.P. — Casey Tansey · latest filing Dec 14, 2022
- Ceribell, Inc. — Rebecca Robertson · latest filing Sep 29, 2022
- CERAPEDICS INC — Greg Garfield · latest filing Mar 7, 2022
- U.S. Venture Partners XIII-A, L.P. — Casey Tansey · latest filing Feb 24, 2022
- Sight Sciences, Inc. — Valeska Schroeder · latest filing Dec 10, 2020
- Celebrands, LLC — John Howard · latest filing Sep 10, 2020
- NeuroPace Inc — Greg Garfield · latest filing Aug 31, 2020
- Apollo Endosurgery, Inc. — Matthew S. Crawford · latest filing Jul 30, 2020
- Cardiva Medical, Inc. — Matthew S. Crawford · latest filing Jul 14, 2020
- Cardiva Medical, Inc. — Michael Bornitz · latest filing Jul 14, 2020
- PTV CM SPV, LLC — Matthew S. Crawford · latest filing Jul 8, 2020
- Parallel Systems, Inc. — John Howard · latest filing Jul 2, 2020
- Sebacia, Inc. — Rebecca Robertson · latest filing Sep 13, 2019
- Sebacia, Inc. — Charles Larsen · latest filing Sep 13, 2019
- Sebacia, Inc. — Gerard van Hamel Platerink · latest filing Sep 13, 2019
- U.S. Venture Partners XII-A, L.P. — Casey Tansey · latest filing Jul 12, 2019
- Heartflow, Inc. — Casey Tansey · latest filing Jun 14, 2019
Shared address: this business address appears on no other issuer's filings in our index. As of Oct 23, 2026, 5:45 PM ET.
Other offering types (Regulation A and Regulation Crowdfunding)
Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.
Adviser registration (Form ADV)
Searched SEC Form ADV bulk data (registered + exempt reporting advisers) (24,962 records as of Oct 2, 2026, 8:00 AM ET) — nothing matched Intuity Medical, Inc..
Meta advertising
No Meta Pixel ids or Facebook / Instagram page links on file for Intuity Medical, Inc. as of Oct 24, 2026 — the sponsor website is read for them once it is on file (runs automatically). Meta Ad Library: not searched by PartnerFacts (no API access); a one-tap Ad Library search is under Look further.
Public profiles
Public profiles official links and public statements, each with its source and date
No website or social profile named in Intuity Medical, Inc.'s SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #235,136 of 374,652 in line (14 issuers searched so far).
Sources searched for a website: Form C data set (issuer websites as filed), Form ADV data set (Item 1.I of matched advisers) — as of Oct 23, 2026, 11:20 PM ET: none on file for this issuer. The sponsor website, the Internet Archive and GDELT news index are read only once a site is on file; a sponsor's website comes from the issuer's own filings (Form C issuer website; EDGAR company profile), an approved profile claim, Form ADV Item 1.I of its matched adviser, or a web search for the issuer name confirmed on the site's own homepage. We never collect personal or family accounts.
Entity standing: not checked (no official programmatic source for CA yet).
Export this report as PDF (all source links + data timestamp) · Premium
Request diligence pack (Premium) PartnerFacts asks the sponsor for the standard information pack and delivers it to you labelled "provided by the sponsor".
Corrections log
No corrections have been requested for this page.
Filing-to-filing changes are in Amendment history above.